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Survival after severe traumatic shock can be complicated
by a number of pathophysiologic processes that ensue
after the initial trauma. One of these is trauma-induced
coagulopathy (TIC) whose onset may occur before initial
fluid resuscitation. The pathogenesis of TIC has not yet
been fully elaborated, but evolving evidence appears to
link severe tissue hypoxia and damage to the endothe-
lium as key factors, which evolve into measurable struc-
tural and biochemical changes of the endothelium
resulting in a coagulopathic state. This paper will provide
a general review of these linkages and identify knowledge
gaps as well as suggest new approaches and areas of
investigation, which may both limit the development of
TIC as well as produce insights into its pathophysiology. A
better understanding of these issues will be necessary in
order to advance the practice of remote damage control
resuscitation.
T
he coagulopathy of trauma, now termed
acute traumatic coagulopathy or trauma-
induced coagulation (TIC), has generally been
viewed as resulting from a combination of
factors beginning with loss of coagulation factors from
hemorrhage, followed by hemodilution by crystalloid
resuscitation, and then exacerbated by ensuing acidosis
and hypothermia that occurs during the course of
ongoing hemorrhage and resuscitation. However, new
evidence strongly suggests that TIC begins earlier occur-
ring before fluid resuscitation and without significant
consumption of coagulation factors.1
Early TIC is characterized by anticoagulation and
hyperfibrinolysis that is likely modulated through the
protein C pathway. Specifically, it has been postulated
that thrombin binding to thrombomodulin contributes
to hyperfibrinolysis via activated protein C consumption
of plasminogen activator inhibitor-1 (PAI-1).2 An increase
in thrombomodulin expression on the endothelium
complexes with thrombin, which then activates protein
C. This complexed thrombin is now no longer available
for its usual hemostatic role of cleaving fibrinogen to
form fibrin. Subsequent consumption of PAI-1 by acti-
vated protein C contributes to an evolving state of
hyperfibrinolysis.
As proposed by Brohi and colleagues, the initiating
and perhaps sustaining factor in the development of TIC
appears to be severe tissue hypoperfusion and tissue
hypoxia.2-4 When coagulation has been studied early after
trauma, only patients who are in shock as indicated by
increased base deficits were noted to have coagulopathy
before fluid resuscitation and without the presence of
hypothermia.3 This is not surprising since severe shock
resulting in tissue hypoperfusion as a function of
elevated base deficit on admission has been known to be
an independent predictor of morbidity and mortality
after trauma with this hypoperfusion not necessarily
equated with the severity of injury as reflected in Injury
Severity Scores.5,6
The pathway suggested above also appears logical
given the presence of thrombomodulin normally found in
the endothelium. Its presence theremay be viewed as pro-
tective mechanism since it is able to sequester thrombin
and thus allow for generation of adequate levels of protein
C. This is probably necessary in order to prevent throm-
bosis in the myriad of conditions that can cause low flow
states. However, when this occurs on amass systemic level
as would be expected to occur in severe traumatic shock,
this appropriate local response may then become patho-
logic resulting in a systemic coagulopathic state favoring
initial clotting inhibition. While evidence supports that
this process occurs in patients with significantly elevated
base deficit, the traditional belief that acidosis plays a sig-
nificant role in TIC is questionable, as recent data demon-
strated no significant effect of acidosis on coagulation
until pH becomes less than 7.0.7
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THE MICROCIRCULATION: THE LINK
BETWEEN TRAUMA, HYPOPERFUSION,
AND TIC?
Based on the above theory of early TIC causation, it would
make great sense to focus on the microcirculation as both
a diagnostic and therapeutic target in the prevention and
treatment of TIC. The microcirculation with its endothe-
lial lining is estimated to represent an area 4000-7000 m2
and thus is probably best viewed as perhaps the body’s
largest integrated functional organ system.8,9 The indi-
vidual microcirculatory “unit” composed of the arteriole,
capillary bed, and postcapillary venule is designed to
ensure the delivery of oxygen and other nutrients to
tissues in excess of their needs as well as to remove prod-
ucts of metabolism. The endothelial lining of the micro-
circulation itself representing some 1013 cells is a major
target of exploration in critical illness and injury, and con-
tinued discovery is constantly revealing an ever greater
level of complexity in external ultrastructure, cellular
makeup, and function.10,11 Complicating its understand-
ing in health and disease is the fact that there is no uni-
versal phenotype for the endothelium and that this
phenotypic heterogeneity is likely to simply be a core
property as it is with the parenchymal cells of other organ
system.10,11 Similar to the parenchymal cellular function of
other organ systems, the cells of the vascular endothelium
play different roles depending on location. For example,
arteriole endothelium plays amajor role in regulating vas-
cular tone through a number of mechanisms such as
signal transduction to vascular smooth muscle via blood
cell to endothelial cell shear stress, while the postcapillary
venular endothelium orchestrates leukocyte trafficking in
response to various injuries.12
Recent attention to the endothelium’s glycocalyx
structure (a combination of proteoglycans and glycopro-
teins) and function are now providing important insights
into themicrocirculatory endothelium’s greater role in the
development of coagulopathy in response to trauma.13,14 A
delicate and dynamic equilibrium exists between the
endothelium glycocalyx and plasma, which normally
resist erythrocyte, leukocyte, and thrombocyte interaction
between the endothelium. This relationship by its very
nature promotes enhanced interaction between the
endothelium and plasma itself. It should not then be sur-
prising that injury to the endothelium especially at the
level of themicrocirculation would be intricately linked to
the coagulopathy of trauma. Recent works demonstrating
the shedding of syndecan-1 (the major cell membrane
protein of the glycocalyx) in response to trauma and hem-
orrhage and its modulation via different resuscitation
strategies favoring plasma to restore the glycocalyx rather
than crystalloid are providing tantalizing first insights into
the potential for early homeostatic resuscitation and
repair of this major organ system.13-19 These complex
interactions also help in understanding the interactive
play and crosstalk between the coagulation and inflam-
matory systems to an extent that really make the two
systems inseparable.
TISSUE HYPOPERFUSION AND THE
MICROCIRCULATION: RECIPE FOR
INITIATION AND SUSTAINMENT
The physiologic characteristics of the microcirculation
such as the longitudinal oxygen gradients along tissue vas-
cular beds, its lower hematocrit, and thus the heterogene-
ity of oxygen delivery may make it particularly at risk for
hypoxic insults. The TIC described in patients (especially
early changes) has been difficult to study in detail. Several
factors may be responsible for this including 1) the diffi-
culty in obtaining detailed coagulation parameters and
indices in a significant number of traumatically injured
patients before traditional fluid resuscitation (traditional
crystalloid ormassive transfusion protocols); 2) the lack of
more early detailed and continuous measures of tissue
perfusion; and 3) the lack of high fidelity large animal
preclinical models specifically examining coagulation
parameters before resuscitation. In regard to this last
point, a potentially complicating factor given that swine
are the favored large animal model of traumatic shock is
the argument that swine are hypercoagulable thusmaking
it more difficult for models utilizing swine to produce
coagulation profiles similar to those of humans.20
However, new evidence as well as the reiteration of well-
known (but sometimes forgotten) physiologic principles
may lend insight into developing preclinical and clinical
studies, which may further link the interplay between
tissue hypoperfusion, tissue hypoxia, and microcircula-
tory endothelial damage. Briefly revisiting these concepts
may help explainmuch of the variation reported in animal
models and between patients as well as help refocus some
of the debate in regard to the value and use of resuscita-
tion protocols such as massive transfusions.
Traditional preclinical models of hemorrhagic shock
have utilized the concepts of volume or pressure control
hemorrhage and time as a means to control for the sever-
ity of hypoperfusion caused by hemorrhage.21 Unfortu-
nately, because of the individual compensatory response
to trauma, neither of these models results in a uniform
metabolic response as indicated by themeasure of oxygen
debt. As early as the 1960s it has been repetitively shown
that hemorrhage to a specific oxygen debt as measured
through indirect calorimetry could result is a wide varia-
tion of hemorrhage volumes among animals.22-28 Oxygen
debt is the accumulation of multiple oxygen deficits over
time. Oxygen deficit is the difference between basal
oxygen consumption and the oxygen consumption at an
oxygen delivery level that does not meet aerobic oxygen
consumption demands (shock).27 To date, oxygen debt is
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the only physiologic measure that has clearly been linked
to both mortality and even morbidity in the form of mul-
tiple organ failure after shock.27 The degree of oxygen debt
incurred after injury has also been clearly linked to inflam-
mation.24,29,30 This again should not be surprising since in
reality oxygen debt can be viewed as a measure of whole
body ischemia. While lactate is also a measure of oxygen
debt it lacks the precision of indirect calorimetry, and
more importantly, because of the biphasic nature of the
oxygen delivery and oxygen consumption in regard to
critical oxygen delivery (Fig. 1), its resolution during
resuscitation does not ensure the important repayment
and resolution of oxygen debt.27While the biphasic nature
of oxygen delivery and consumption as outlined in Fig. 1
is generally viewed in light of central oxygen transport and
hemodynamics, it should be understood that this rela-
tionship exists at each individual organ level as is gov-
erned in large part at the level of the microcirculation.
Unfortunately, precise measures of oxygen debt in
humans using indirect calorimetry require knowledge
of baseline oxygen consumption, which itself can vary
widely.31,32 Since many recent animal laboratory reports
examining various blood product resuscitation strategies
lack themeasure of oxygen debt it is truly difficult tomake
comparisons of effectiveness both between treatment
groups as well as between studies in regard to both the
severity of tissue hypoperfusion and the effectiveness in
treatments in repaying oxygen debt.33-38 In addition, lack
of more precise measures of hypoperfusion and tissue
hypoxia makes it challenging in exploring the link of these
triggers in the development of TIC and its treatment.
Figure 2 provides evidence for the
individual variation in response as
linked to the microcirculation and to
treatment response. Anesthetized swine
subjected to soft tissue injury and arte-
rial hemorrhage were monitored for
oxygen debt using indirect calorimetry.
In addition, the animal’s sublingual
microcirculation was monitored using
sidestream dark-field (SDF) video-
microscopy.39 This measure has been
demonstrated to track whole body per-
fusion in sepsis and cardiogenic shock
and is now being used to target hemor-
rhage as changes in the microcircula-
tion have been found to occur earlier
than changes in mean arterial pressure
in response to central volume changes.40
Figure 2A demonstrates the typical
swine microcirculation at baseline.
Figure 2B and 2C demonstrate the
microcirculation of two animals at an
oxygen debt accumulation of 80 mL/kg.
The animal from Fig. 2B had 30% of its
blood volume removed compared with 50% of total blood
volume removed in the animal pictured in Fig. 2C. In
both animals a significant reduction in fibrinogen was
noted coupled with a significant reduction in the
Maximum Amplitude on thromboelastrography (TEG).
Fig. 1. The biphasic relationship of oxygen delivery (DO2) and
oxygen consumption (VO2). As DO2 decreases, VO2 may remain
constant due to an increase in the ratio of extracted oxygen
(OER) at the tissue level. This is mirrored by a decrease in
venous hemoglobin oxygen saturation (SvO2). However, at
some point OER will not meet VO2 demands of the tissues
resulting in a state of DO2-dependent VO2 whereby aerobic
VO2 transitions to anaerobic VO2. At this point of critical DO2,
oxygen debt begins to accumulate along with metabolic
byproducts of anaerobiosis such as lactate.While this rela-
tionship exists for the body as a whole, it also exists for each
individual organ system and is largely mediated by the
microcirculation.
Fig. 2. Microcirculatory images of the swine sublingual surface using sidestream
dark-field microscopy at a 167 ¥ magnification. See text for details.
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The animals required 60 and 90 minutes, respectively, to
reach an oxygen debt of 80 mL/kg. The animal in Fig. 2B
did not survive a whole blood resuscitation. The animal in
Fig. 2C survived but had a rocky course. Finally, themicro-
circulation pictured in Fig. 2D is from an animal at 1 hour
after 50% blood volume has been removed. This animal
had an oxygen debt of 40 mL/kg at 60 minutes at which
time it was resuscitated with whole blood and easily sur-
vived. As can be noted there are striking differences
among these three examples in regard to hemorrhage
volumes, shock times, oxygen debts, and the microcircu-
lation. This variation from individual to individual in
animals is really no different from that in humans.
However, as careful inspection of the animal hemorrhagic
shock literature would indicate, the compensatory and
physiologic reserves of young animals likely require sig-
nificantly greater insults including the depth of shock to
produce metabolic and coagulation abnormalities similar
to humans who have less capacity for compensation and
are not anesthetized as most animal models are. Rarely is
enough attention paid to limit and control for individual
variation in animal models of traumatic shock, and
evidence exists that if the shock state is deep and con-
trolled enough, coagulopathy begins to develop before
treatment.41-43
More attention to animal model design and monitor-
ing may provide for new critical insights into the relation-
ship between injury severity, TIC, and its treatment. The
importance of this is difficult to overstate especially as
more inflammatory and other mediators such as cat-
echolamine levels are being associated with TIC.16-19,44
Whether or not they are causal or simply associated with
the degree of oxygen debt and thus microcirculatory
tissue hypoxia remains to be determined. Even time-
honored teachings of the dangers of hypothermia in
traumamust be viewed in light of tissue hypoxia since the
hypothermia of traumatic shock that is not due to envi-
ronmental factors is related to the fact that oxygen con-
sumption and temperature are tightly linked through
tissue perfusion.
The compilation of these findings coupled with the
fact that nonhemorrhage stagnant ischemia and simple
hypoxia in cell culture is capable of causing similar
damage to the endothelium and its glycocalyx lining,
point to tissue hypoxia and a common initiator of micro-
circulatory endothelium damage.45-48 As indicated above,
the depth and degree of this hypoxia appear to be critical.
However, it is also likely, given the tentacle nature and
thickness of the glycocalyx, that the biomechanics of flow
may play a role in damage as patients undergoing aortic
aneurysm repair under deep hypothermic circulatory
arrest and not expected to have typical warm ischemia
also demonstrate evidence of endothelial damage by the
shedding of syndecan-1.45 Important issues of biome-
chanical interactions of resuscitation strategies need
further investigation given the tremendous differences
that likely exist between crystalloid, colloid, and blood
component resuscitation ranging from viscosity and rheo-
logic issues to electrostatics and redox potential.49 The
known surface negative electrostatic charge distribution
existing on red and white cells and that of the endothe-
lium cannot be discounted as an important modulator
of damage and repair that are linked to tissue hypoxia
and flow-related initiators of damage.50-53 Lastly, simple
mechanical tissue damage itself is likely to play an impor-
tant role between the microcirculation and TIC if damage
is significant enough. This is evidenced by animal models
of trauma producing TIC such as Noble-Collip drum
shock in which severe tissue injury but not gross hemor-
rhage is produced.54,55 Thus severe soft tissue injury in
which a sufficient amount of microvasculature is injured
may be capable of producing TIC to a degree similar
to severe hemorrhagic shock. A degree of mechanical
damage this great would also be expected to result in
severe local microcirculatory tissue hypoxia.
TRANSLATIONAL IMPLICATIONS FOR
MONITORING AND TREATMENT
If indeed there is a critical link between tissue hypoperfu-
sion, tissue hypoxia, and TIC, it would seem reasonable to
explore and invest in monitoring technologies and strate-
gies thatallows forabetterearlyandreal-timeappreciation
of both the degree of shock as well as its resolution as an
endpoint. While use of base deficit and lactate as initial
screening tools are now fairly ubiquitous for the initial
evaluation of the trauma patient, their utility does have
some important limitations given the continuum of injury
and treatment. As noted in Fig. 1, lactate as an indicator of
hypoperfusion and tissue hypoxia rises only after oxygen
extraction ismaximized by tissues as oxygen consumption
becomes directly dependent on oxygen delivery. In addi-
tion as patients are resuscitated, anaerobic lactate produc-
tion will stop once oxygen delivery is above a critical level,
and lactate previously produced will begin to be metabo-
lized. However, tissuesmay still be lacking oxygen delivery
levels required to pay back oxygen debt, which may be
evidenced by higher than normal levels of oxygen extrac-
tion ratios.27Despite this, newpoint-of-care lactatedevices
are nowavailable and their distribution anduse during the
various echelons of care including theprehospital phase of
care should be considered as multiple lactate levels over
time are more important than single measures.56 Thus
measures beginning near the time of injury and forward
may give a better indication of the degree of accumulated
oxygen debt before all-out resuscitation.
Based on the relationship between oxygen delivery,
oxygen consumption, and oxygen extraction, the use of
tissue hemoglobin oxygen saturation (StO2) monitor-
ing is attractive. StO2 monitoring using a number of
THE MICROCIRCULATION
Volume 53, January 2013 Supplement TRANSFUSION 41S
spectroscopy techniques such as near infrared (differen-
tial absorption), resonance Raman (vibrational) are being
explored as both quantitative shock indicators as well as
endpoints of resuscitation.57-60 The value of StO2 monitor-
ing is based on the knowledge that for any given volume of
tissue, approximately 70%-80% of blood in that tissue
resides in the venous compartment while the other 20%-
30% resides in the arteriolar and capillary compart-
ments.61 Thus spectroscopy techniques capable of
providing an aggregate measure of hemoglobin StO2 in a
segment of tissue provide a value that is dominated by the
venous or postextraction component. Because of the bio-
photonic principles undergirding these measures, StO2 is
a reflection of microcirculatory tissue oxygenation. If a
tissue bed is chosen that has a reasonable level of basal
oxygen extraction and is sensitive to deprivation of blood
flow, StO2 may then be able to serve as an early warning
indicator of the presence and degree of tissue hypoxia
(even before significant changes in vital signs) as well as
an endpoint of resuscitation ensuring at least that oxygen
extraction levels are not at levels simply above critical
oxygen delivery but instead are at levels consistent with
normal metabolism and thus perhaps reflective of the
repayment of oxygen debt. When used with pulse oxim-
etry, regional oxygen extraction ratios (OER) can be calcu-
lated as SpO2—StO2/SpO2. This would be similar to
systemic (OER) levels using central or mixed venous
hemoglobin StO2.32,62 Again, certain caveats will apply
such as choosing a peripheral tissue site that at least is
capable of reflecting whole body changes in OER. Current
tissue sites being explored are the skeletal muscle sites in
the hand and forearm as well as the buccal mucosa. Use of
technologies, such as near infrared spectroscopy for skel-
etal muscle, presents some challenges, since myoglobin
and hemoglobin have identical absorption spectra, which
exists in equal concentration gram for gram in tissue but
with myoglobin having a significantly lower p50 than
hemoglobin (5 mmHg vs. 26 mmHg respectively).63 The
ability of StO2 to mimic and track changes in central or
mixed venous hemoglobin (ScvO2) may be important in
regard to TIC, since ScvO2 has been demonstrated to be
significantly associated with changes in TEG Maximum
Amplitude during traumatic shock.64 Again, the relation-
ship between ScvO2 and the balance between oxygen con-
sumption and delivery (Fig. 1) as it pertains to oxygen
debt make both ScvO2 and its potential surrogate of StO2
attractive. As Fig. 1 would suggest, successful creation and
implementation of an StO2 monitor with sufficient sensi-
tivitymight allow detection of tissue hypoxia before reach-
ing a level of critical oxygen delivery as well as ensure
more complete resuscitation other than simple lactate
clearance. Use of StO2 monitoring at earlier echelons of
care as a diagnostic and therapeutic endpoint might have
great potential to reduce TIC if in fact microcirculatory
tissue hypoxia is the link between trauma andTIC.To date,
however, StO2 has not been studied as prospective driver
of interventions such as transfusion.
The use of SDF microscopy to directly visualize the
microcirculation as noted in Fig. 2 is another technology
that may provide important diagnostic and therapeutic
potential. Using wavelengths of light in the 500-600 nm
range (which is absorbed by the red cell hemoglobin inde-
pendent of oxygenation state) and special optics, this
technique allows real-time visualization of the microcir-
culation in an approximately 1 mm2 field of view and at
depths of 100-200 micrometers with 167 ¥ magnifica-
tion.39,65 The resolution of this techniquewill not, however,
allow for visualization of the glycocalyx. The technique
can only be used on mucosal surfaces and the vast major-
ity of use has been focused on the easily accessible sub-
lingual mucosa, which appears to be sensitive to a variety
of perfusion insults ranging form sepsis to hemor-
rhage.40,66,67 Several perfusion indices have been devel-
oped including functional capillary or perfused vessel
density and grades of flow.68 These indices have shown
significant correlation with outcome and treatments.
While it has mainly been studied in the setting of sepsis
and cardiogenic shock, it is likely to have significant impli-
cations in hemorrhage as a means to better detect com-
pensatory states of shock as well as having the potential to
be a surrogate for microcirculatory damage and/or ensur-
ing restoration of microcirculatory flow and tissue oxy-
genation, which are likely to be key in allowing for the
repayment of oxygen debt.While better software tools are
needed to allow faster and more quantitative image
metrics, its use may still allow for important insights.
Perhaps its use in preclinical models of traumatic shock
might ensure animals all have similar levels of microcir-
culatory hypoperfusion in order to reduce individual
variability.
There are a plethora of other techniques, which may
prove to be valuable in the rapid assessment of the patient
with traumatic shock. All have their value and basis in
microcirculatory blood flow and tissue oxygenation.69
These include but are not limited to tissue capnometry
(remembering that CO2 production is tightly coupled to
oxygen consumption) and new laser Doppler flowmetry
techniques.69-71 Newer biochemical point-of-care tech-
nologies may also prove to be helpful such as inflamma-
tory cytokine markers and, as discussed earlier, even
markers specific to the endothelium such as syndecan-
1.14,18 However, the question as to whether these markers
can change early enough to be diagnostically helpful or to
guide rapid resuscitation remains to be seen as do their
value over other measures of perfusion. The use of mea-
sures such as ambient redox potential (the electronic
balance between all oxidants and reductants) may prove
to be of great utility as there is early evidence that it is
linked to both tissue hypoxia and that important media-
tors of coagulation such as fibrinogen are extremely sus-
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ceptible to oxidative damage, which significantly reduces
its function despite having no effect on total fibrinogen
levels.72-74
Lastly, it is now being suggested that early goal-
directed coagulation management of trauma patients
takes place using viscoelastic measures of coagulation
function such as thromboelastography and that the early
use of thesemeasures is predictive of the need formassive
transfusion.75,76 While this will likely be a very helpful
adjunct, based on the evidence and principles discussed
above, it should not distract from our developing better
real-time measures of tissue perfusion. Again, the devel-
oping linkages between tissue hypoxia and TIC would
indicate that monitoring for the presence and degree of
tissue hypoxia and aggressively treating it to resolution
may do themost for both identifying thosemost at risk for
TIC and limiting its development. By doing so, we may be
able to better understand by whichmechanisms therapies
are better able to result in a reduced incidence of TIC. As
an example of this, it could be postulated that the better
outcomes observed in a number of studies examining the
use of massive transfusion protocols result in better
outcome simply because the use of whole blood or recon-
stituted whole blood through the use of component
therapy is due to the fact that these may be better resus-
citation fluids capable of restoring tissuemicrocirculatory
flow and oxygenation than crystalloids. Conversely these
technologies may explain why massive transfusion proto-
cols are not a cure all. Use of such technologies may also
allow us to understand which components of fractioned
blood (plasma vs. red cells vs. platelets), and in which
ratios, may be most helpful while controlling for the
initial variation in individual tissue hypoperfusion and
hypoxia.77-82 Such studies would be informative given sug-
gestions that the combination of colloid resuscitation
coupled with fibrinogen and prothrombin complex
concentrate may be capable of producing similar
outcomes.83-85 Since the physiology of casualties will
change drastically over short periods of time (especially
themore severely injured they are), it will be imperative to
study technologies that are capable of detecting and
quantifying tissue hypoxia as early after injury as possible
in order to ascertain their value for remote damage control
resuscitation. In order to do this, technologies will need to
be trialed in the prehospital civilian trauma setting before
and during resuscitation. To date, no large-scale prehos-
pital trauma tissue perfusion monitoring studies have
been reported. Additional challenges in this regard will be
the need for miniaturization and ruggedization of such
devices, which provide simple and clearly actionable data.
Given the size and phenotypic complexity of the
microcirculation and likely similar linkages between
tissue hypoxia, coagulation, and inflammation in shock
states, a systems biology approach to its study should be
considered.86 It can be argued that trauma and other
shock states result in an endotheliopathy or microcircul-
opathy. With the advent of high throughput “omic” and
computational tools, a rich opportunity exists to study the
system in its whole complexity as a physiome if dynamic
measures such as flow and oxygenation are included. This
would help to ensure that we do not miss important rela-
tionships in the network as sadly happens too often in our
traditional reductionist approaches.
CONCLUSION
Mounting evidence links the initial and ongoing systemic
microcirculatory tissue hypoperfusion and hypoxia of
trauma with the development of TIC. Severe systemic
tissue hypoperfusion and hypoxia of the massive organ of
the microcirculation likely turns a homeostatic response
to tissue hypoperfusion meant to prevent clotting to one
of pathogenesis when a critical mass of the microcircula-
tion is injured as would occur in severe traumatic shock.
The mechanical and biochemical properties of the mirco-
circulation and its endotheliumappear to put it at particu-
lar risk for damage due to hypoperfusion and hypoxia.
Renewed emphasis on the development and application
of technologies designed to interrogate and report the
status of the microcirculation in response to injury and
treatment may offer the best hope of mitigating ensuing
complications such as TIC by allowing greater insights
into presence and depth of tissue hypoxia as well as in
developing the best therapies that rapidly restore micro-
circulatory tissue oxygenation and health.
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